DIFFERENCES IN THE EFFECTS OF HOST SUPPRESSION ON THE ADOPTIVE IMMUNOTHERAPY OF SUBCUTANEOUS AND VISCERAL TUMORS

被引：0
|
作者：
CHANG, AE
SHU, S
CHOU, T
LAFRENIERE, R
ROSENBERG, SA
机构：
来源：
CANCER RESEARCH | 1986年 / 46卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3426 / 3430
页数：5
相关论文
共 50 条
  • [41] Natural Killer Cells Require Selectins for Suppression of Subcutaneous Tumors
    Sobolev, Olga
    Stern, Patrick
    Lacy-Hulbert, Adam
    Hynes, Richard O.
    CANCER RESEARCH, 2009, 69 (06) : 2531 - 2539
  • [42] Proadipogenic effects of lactoferrin in human subcutaneous and visceral preadipocytes
    Maria Moreno-Navarrete, Jose
    Ortega, Francisco
    Sabater, Monica
    Ricart, Wifredo
    Manuel Fernandez-Real, Jose
    JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2011, 22 (12): : 1143 - 1149
  • [43] Functional Differences in Visceral and Subcutaneous Fat Pads Originate from Differences in the Adipose Stem Cell
    Baglioni, Silvana
    Cantini, Giulia
    Poli, Giada
    Francalanci, Michela
    Squecco, Roberta
    Di Franco, Alessandra
    Borgogni, Elisa
    Frontera, Salvatore
    Nesi, Gabriella
    Liotta, Francesco
    Lucchese, Marcello
    Perigli, Giuliano
    Francini, Fabio
    Forti, Gianni
    Serio, Mario
    Luconi, Michaela
    PLOS ONE, 2012, 7 (05):
  • [44] Functional Differences in Visceral and Subcutaneous Fat Pads Originate from Differences in Adipose Stem Cells
    Nesi, G.
    Baglioni, S.
    Paglierani, M.
    Cantini, G.
    Poli, G.
    Forti, G.
    Luconi, M.
    LABORATORY INVESTIGATION, 2012, 92 : 464A - 465A
  • [45] Functional Differences in Visceral and Subcutaneous Fat Pads Originate from Differences in Adipose Stem Cells
    Nesi, G.
    Baglioni, S.
    Paglierani, M.
    Cantini, G.
    Poli, G.
    Forti, G.
    Luconi, M.
    MODERN PATHOLOGY, 2012, 25 : 464A - 465A
  • [46] Protection from tumor recurrence following adoptive immunotherapy varies with host conditioning regimen despite initial regression of autochthonous murine brain tumors
    Cozza, Eugene M.
    Cooper, Timothy K.
    Budgeon, Lynn R.
    Christensen, Neil D.
    Schell, Todd D.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2015, 64 (03) : 325 - 336
  • [47] Protection from tumor recurrence following adoptive immunotherapy varies with host conditioning regimen despite initial regression of autochthonous murine brain tumors
    Eugene M. Cozza
    Timothy K. Cooper
    Lynn R. Budgeon
    Neil D. Christensen
    Todd D. Schell
    Cancer Immunology, Immunotherapy, 2015, 64 : 325 - 336
  • [48] Host conditioning approach and choice of target epitope determine the success of adoptive T cell immunotherapy against oncogene-induced established tumors
    Ward-Kavanagh, Lindsay
    Cooper, Timothy
    Schell, Todd
    JOURNAL OF IMMUNOLOGY, 2013, 190
  • [49] IMMUNOLOGICAL EFFECTS OF ADOPTIVE IMMUNOTHERAPY WITH IL-2 - AN OVERVIEW
    KRADIN, R
    YAMIN, R
    KURNICK, J
    PATHOLOGY AND IMMUNOPATHOLOGY RESEARCH, 1988, 7 (06): : 434 - 441
  • [50] Protocol for delivery of intraoperative immunotherapy to mice by surgical debulking of subcutaneous tumors
    Rwandamuriye, Francois Xavier
    Vitali, Breana
    Schreurs, Juliet
    Wang, Tao
    Barrick, Emily
    Iyer, Killugudi Swaminathan
    Lesterhuis, Willem Joost
    Zemek, Rachael M.
    Wylie, Ben
    STAR PROTOCOLS, 2024, 5 (02):
12345